Literature DB >> 10398276

Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames.

C K Choo1, M T Ling, K W Chan, S W Tsao, Z Zheng, D Zhang, L C Chan, Y C Wong.   

Abstract

BACKGROUND: The exact pathogenesis for prostate cancer is not known. Progress made in prostate cancer research has been slow, largely due to the lack of suitable in vitro models. Here, we report our work on the immortalization of a human prostate epithelial cell line and show that it can be used as a model to study prostate tumorigenesis.
METHODS: Replication-defective retrovirus harboring the human papillomavirus (HPV) type 16 E6 and E7 open reading frames was used to infect primary human prostate epithelial cells. Polymerase chain reaction, followed by Southern hybridization for the HPV 16 E6/E7, Western blot for prostatic acid phosphatase, telomeric repeat amplification protocol assay for telomerase activity, two-dimensional gels for cytokeratins, and cytogenetic analysis were undertaken to characterized the infected cells.
RESULTS: The retrovirus-infected cell line, HPr-1, continued to grow in culture for more than 80 successive passages. Normal primary cells failed to proliferate after passage 6. HPr-1 cells bore close resemblance to normal primary prostate epithelial cells, both morphologically and biochemically. However, they possessed telomerase activity and proliferated indefinitely. Cytogenetic analysis of HPr-1 cells revealed a human male karyotype with clonal abnormalities and the appearance of multiple double minutes.
CONCLUSIONS: The HPr-1 cells expressed prostatic acid phosphatase and cytokeratins K8 and K18, proving that they were prostate epithelial cells. They were benign in nude mice tumor formation and soft agar colony formation assay. The HPr-1 cell line is an in vitro representation of early prostate neoplastic progression. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398276     DOI: 10.1002/(sici)1097-0045(19990801)40:3<150::aid-pros2>3.0.co;2-7

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  14 in total

1.  Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population.

Authors:  R C Sobti; J Kochar; K Singh; D Bhasin; N Capalash
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

2.  Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis.

Authors:  Y Lin; Q Mao; X Zheng; K Yang; H Chen; C Zhou; L Xie
Journal:  Ir J Med Sci       Date:  2011-03-12       Impact factor: 1.568

3.  [Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance?].

Authors:  M May; R Kalisch; B Hoschke; T Juretzek; F Wagenlehner; S Brookman-Amissah; I Spivak; K-P Braun; W Bär; C Helke
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

4.  No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses.

Authors:  Harriet C T Groom; Anne Y Warren; David E Neal; Kate N Bishop
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

5.  Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells.

Authors:  Yung-Tuen Chiu; Ji Liu; Kaidun Tang; Yong-Chuan Wong; Kum Kum Khanna; Ming-Tat Ling
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

6.  Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.

Authors:  Young-Chae Kim; Congcong Chen; Eric C Bolton
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

7.  Promising noninvasive cellular phenotype in prostate cancer cells knockdown of matrix metalloproteinase 9.

Authors:  Aditi Gupta; Wei Cao; Kavitha Sadashivaiah; Wantao Chen; Abraham Schneider; Meenakshi A Chellaiah
Journal:  ScientificWorldJournal       Date:  2013-02-06

8.  Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.

Authors:  Aditi Gupta; Wei Cao; Meenakshi A Chellaiah
Journal:  Mol Cancer       Date:  2012-09-11       Impact factor: 27.401

9.  Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells.

Authors:  Aditi Gupta; Cindy Q Zhou; Meenakshi A Chellaiah
Journal:  Cancers (Basel)       Date:  2013-05-27       Impact factor: 6.639

10.  Viral infections in prostate carcinomas in Chilean patients.

Authors:  Hector Rodríguez; Jorge Levican; Juan P Muñoz; Diego Carrillo; Mónica L Acevedo; Aldo Gaggero; Oscar León; Tarik Gheit; Omar Espinoza-Navarro; Jorge Castillo; Iván Gallegos; Massimo Tommasino; Francisco Aguayo
Journal:  Infect Agent Cancer       Date:  2015-09-01       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.